$16.9M
1 filing since 2024 · latest Equity filed
Third Pole, Inc. is an innovative biotechnology company dedicated to developing and delivering essential life-sustaining therapies for cardiopulmonary conditions. The company specializes in creating portable, tankless inhaled nitric oxide (iNO) delivery systems to enhance accessibility and patient care.
What sets it apart
Third Pole stands out by providing portable, on-demand nitric oxide generation that liberates the therapy from traditional large tanks, making it more accessible for both hospital and home use.
eNOfit™ is a miniaturized, wearable device designed for home and travel use that enables patients to receive inhaled nitric oxide therapy conveniently in their daily lives. This device allows for greater patient mobility and independence.
